Related Experiment Video
Updated: May 29, 2026
10:32
Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
Improving treatment adherence in patients with schizophrenia
1Department of Psychiatry, The Zucker Hillside Hospital, Glen Oaks, NY, USA.
The Journal of Clinical Psychiatry
|September 29, 2011
Summary
Nonadherence to antipsychotic medications poses significant challenges in schizophrenia treatment, leading to relapse and hospitalization. Strategies to improve medication adherence, such as long-acting injections, are crucial for better patient outcomes.
Area of Science:
- Psychiatry and Pharmaceutical Sciences
- Clinical Psychology and Behavioral Health
Background:
- Nonadherence to antipsychotic medications is a major obstacle in schizophrenia management.
- Poor adherence is linked to increased relapse rates, hospitalizations, and suicide attempts.
Discussion:
- Accurate assessment of medication adherence is challenging due to patient underreporting.
- Strategies for improving adherence are essential for effective schizophrenia treatment.
- Long-acting injectable antipsychotics offer a promising approach to enhance adherence.
Key Insights:
- Patients often overestimate their adherence, complicating clinical assessment.
- Targeted interventions are needed to address the complexities of medication adherence.
- Long-acting depot formulations can improve treatment consistency.
Outlook:
- Further research into novel adherence monitoring tools is warranted.
- Personalized adherence strategies may improve long-term schizophrenia management.
- Integrating adherence support into routine clinical practice is vital.
Related Concept Videos
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:29Psychological and Sociocultural Causes of Schizophrenia
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...